Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer
about
Epigenetic impact of infection on carcinogenesis: mechanisms and applicationsEpigenetic susceptibility factors for prostate cancer with aging.A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activationEpigenetic modifications of caveolae associated proteins in health and disease.Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancerSix stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.Cancer subclonal genetic architecture as a key to personalized medicine.Global DNA hypomethylation in prostate cancer development and progression: a systematic review.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.Addressing the need for repeat prostate biopsy: new technology and approaches.Widespread telomere instability in prostatic lesions.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer.Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues.
P2860
Q28066519-291818C5-1686-43A8-9654-6400A44BC2CAQ34541756-5FEEA4E5-90B6-4836-880A-04236BCC1D63Q35099514-71CE8C9B-3970-4A7E-B2C7-5D7D54890412Q35674847-AA5FF28D-B78A-4663-A082-CD1F8E08375BQ36061986-F39FCDE9-6B1E-4F16-987E-34CC8B2E1167Q36140962-86BCE01D-6122-43E4-954E-AA496F3608F6Q37448116-7E992B57-537F-40DE-AB2B-04047A9299ADQ38266607-23CA6C22-A5EB-418E-AF61-728C0FA3CEBDQ38269155-99810B65-E647-4FD1-8B9C-D17DCC4A5FFAQ38546671-334EA5B3-E037-4F5A-8063-F7094A8A6CE4Q38881676-C97F6DF6-644A-4261-9A16-51D415D93EC8Q41548112-276B3A35-5A0D-4635-B809-636315147848Q42256326-546A1B1E-B523-4160-91D3-56EB4CECFB1FQ42558314-0029A45A-3336-42A2-AD81-D162C4DDB6D9Q42676794-465965C4-D42F-40E0-B7F4-81F77DB2ED15Q47141373-11B98FA2-E7A8-41ED-B364-1A07FF9A27CAQ55317207-496B9BF9-95F8-4BB1-B5DD-A15CB29A6808
P2860
Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Methylation profiling defines ...... ssociated with prostate cancer
@ast
Methylation profiling defines ...... ssociated with prostate cancer
@en
type
label
Methylation profiling defines ...... ssociated with prostate cancer
@ast
Methylation profiling defines ...... ssociated with prostate cancer
@en
prefLabel
Methylation profiling defines ...... ssociated with prostate cancer
@ast
Methylation profiling defines ...... ssociated with prostate cancer
@en
P2093
P2860
P356
P1433
P1476
Methylation profiling defines ...... ssociated with prostate cancer
@en
P2093
David F Jarrard
Glen Leverson
Jennifer Wagner
Jessica Kueck
Pushpa Weeratunga
Sachin Bhusari
P2860
P304
P356
10.1593/NEO.13280
P577
2013-04-01T00:00:00Z